.Novo Nordisk has axed its own once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) develop...
.Merck & Co. has quickly recouped several of the costs of its Harpoon Therapeutics buyout, drawin...
.After BioMarin carried out a spring season tidy of its pipe in April, the firm has actually determi...
.Huge Pharmas continue to be caught to the concept of molecular glue degraders. The most recent busi...
.A brand new international lifestyle scientific research credit scores company, dubbed Symbiotic Res...
.Bristol Myers Squibb is axing another significant bet coming from the Caforio time, ending a deal f...
.After taking a look at stage 1 record, Nuvation Bio has actually chosen to halt deal with its singl...
.Zevra Therapies' rare condition medicine seems to be to become on the path to approval this fall af...
.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has blown a $230 thou...
.After greater than twenty years of focus on neurodegenerative health conditions, Swiss biotech hvac...